Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MANNKIND CORP | EVP Endocrine Business Unit | Common Stock, $0.01 Par Value | 777K | $3.11M | $4.00 | Aug 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MNKD | MANNKIND CORP | Aug 22, 2022 | 2 | -$17.8K | 4 | Aug 23, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | Jul 31, 2022 | 1 | $14.7K | 4/A | Aug 24, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | May 18, 2022 | 1 | $15.3K | 4/A | May 25, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | May 18, 2022 | 1 | -$15.3K | 4 | May 20, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | May 10, 2022 | 2 | $0 | 4 | May 12, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | Feb 28, 2022 | 1 | $100K | 4/A | Aug 24, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | Feb 28, 2022 | 1 | $100K | 4 | Mar 1, 2022 | Chief Commercial Officer |
MNKD | MANNKIND CORP | Jan 31, 2022 | 1 | $5.72K | 4/A | Aug 24, 2022 | EVP Endocrine Business Unit |
MNKD | MANNKIND CORP | Jan 31, 2022 | 1 | $5.72K | 4/A | Feb 9, 2022 | Chief Commercial Officer |
MNKD | MANNKIND CORP | Aug 27, 2021 | 1 | -$47.2K | 4 | Aug 27, 2021 | Chief Commercial Officer |
MNKD | MANNKIND CORP | Jul 30, 2021 | 1 | $15K | 4 | Aug 2, 2021 | Chief Commercial Officer |
MNKD | MANNKIND CORP | May 18, 2021 | 2 | $0 | 4 | May 20, 2021 | Chief Commercial Officer |